Log in

Heart-Type Fatty Acid-Binding Protein, in Early Detection of Acute Myocardial Infarction: Comparison with CK-MB, Troponin I and Myoglobin

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

The study aimed to investigate whether heart-type fatty acid binding protein (H-FABP) measurement provides additional diagnostic value to that of conventional cardiac markers in acute myocardial infarction (AMI) within first 6 h after the onset of symptoms. The study included 120 subjects: 60 AMI cases and 60 age and sex matched controls. The cases and controls were further divided into 2 subgroups depending on the time since onset of chest pain as (1) subjects within 3 h and (2) between 3 and 6 h of onset of chest pain. In all the cases and controls, serum H-FABP concentration was measured by Immunoturbidimetric method, serum Troponin I and myoglobin concentrations by Chemiluminescence immunoassay and serum CK-MB concentration by Immuno-inhibition method. The sensitivity, specificity, positive and negative predictive values of H-FABP were significantly greater than CK-MB and myoglobin but were lesser than Troponin I in patients with suspected AMI in both within 3 h and 3–6 h groups. Receiver operating characteristic curves demonstrated greatest diagnostic ability for Troponin I (AUC = 0.99, p < 0.001) followed by H-FABP (AUC = 0.906, p < 0.001) within 3 h and 3–6 h after the onset of chest pain. In conclusion, the diagnostic value of H-FABP is greater than CK-MB and myoglobin but slightly lesser than troponin I for the early diagnosis of AMI within first 6 h of chest pain. H-FABP can be used as an additional diagnostic tool for the early diagnosis of AMI along with troponin I.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Dienstag JL. Ischemic heart disease. In: Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL, Loscalzo J, editors. Harrison’s principles of internal medicine, vol. 2. 17th ed. New York: McGraw Hill Medical; 2008. p. 1955–69.

    Google Scholar 

  2. Gupta R, Joshi P, Mohan V, Reddy KS, Yusuf S. Epidemiology and causation of coronary heart disease and stroke in India. Heart. 2008;94(1):16–26.

    Article  CAS  PubMed  Google Scholar 

  3. Elmadbouh I, Mahfouz R, Bayomy N, Faried W, Ghanayem N. The value of human heart-type fatty acid binding protein in diagnosis of patients with acute chest pain. Egypt Heart J. 2012;64:179–84.

    Article  Google Scholar 

  4. McMahon CG, Lamont JV, Curtin E, McConnell RI, Crockard M, Kurth MJ, et al. Diagnostic accuracy of heart-type fatty-acid binding protein for the early diagnosis of acute myocardial infarction. Am J Emerg Med. 2012;30:267–74.

    Article  PubMed  Google Scholar 

  5. Alhadi HA, Fox KAA. Do we need additional markers of myocyte necrosis: the potential value of heart type fatty acid binding protein. Q J Med. 2004;97:187–98.

    Article  CAS  Google Scholar 

  6. Wild D, editor. The immunoassay handbook. 2nd ed. London: Nature Publishing Group; 2001.

    Google Scholar 

  7. Bhatia DP, Carless DR, Viswanathan K, Hall AS, Barth JH. Serum 99th centile values for two heart type fatty acid binding protein assays. Ann Clin Biochem. 2009;46(6):464–7.

    Article  Google Scholar 

  8. Kim Y, Kim H, Kim SY, Lee HK, Kwon HJ, Kim YG, et al. Automated heart-type fatty acid binding protein assay for the early diagnosis of acute myocardial infarction. Am J Clin Pathol. 2010;134:157–62.

    Article  CAS  PubMed  Google Scholar 

  9. ARCHITECT Stat Troponin: I [Package Insert]. Abbott Park, IL 60064 USA: Abbott Laboratories; 2010.

  10. ARCHITECT Stat Myoglobin [Package Insert]. Abbott Park, IL 60064 USA: Abbott Laboratories; 2010.

  11. Recommendations of the German Society for Clinical Chemistry. Standardization of methods for the estimation of enzyme activities in biological fluids. Standard method for the determination of creatine kinase activity (1976). J Clin Chem Clin Biochem. 1977;15:255.

    Google Scholar 

  12. Witt I, Trendelenburg C. Joint study to establish reference values for clinical chemical parameters in childhood. J Clin Chem Clin Biochem. 1982;20(4):235–42.

    CAS  PubMed  Google Scholar 

  13. Pasaoglu H, Ofluoglu E, Ilhan MN, Cengel A, Ozdemir M, Durakoglugil E, et al. The role of heart-type fatty acid binding protein (H-FABP) in acute myocardial infarction compared to cardiac biochemical markers. Turk J Med Sci. 2007;37(2):61–7.

    CAS  Google Scholar 

  14. Orak M, Üstündag M, Güloglu C, Özhasenekler A, Alyan O, Kale E. The role of the heart-type fatty acid binding protein in the early diagnosis of acute coronary syndrome and its comparison with troponin I and creatine kinase-MB isoform. Am J Emerg Med. 2010;28:891–6.

    Article  PubMed  Google Scholar 

  15. Alhadi HA, Fox KAA. Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction: the potential for influencing patient management. Sultan Qaboos Univ Med J. 2010;10(1):41–9.

    PubMed  PubMed Central  Google Scholar 

  16. Alansari SE, Croal BL. Diagnostic value of heart fatty acid binding protein and myoglobin in patients admitted with chest pain. Ann Clin Biochem. 2004;41:391–6.

    Article  CAS  PubMed  Google Scholar 

  17. Freund Y, Chenevier-Gobeaux C, Leumani F, Claessens Y, Allo J, Doumenc B, et al. Heart-type fatty acid binding protein and the diagnosis of acute coronary syndrome in ED. Am J Emerg Med. 2012;30:1378–84.

    Article  PubMed  Google Scholar 

  18. Kim KS, Lee HJ, Kim K, Jo YH, Kim TY, Lee JH, et al. Heart-type fatty acid binding protein as an adjunct to cardiac troponin-i for the diagnosis of myocardial infarction. Korean Med Sci. 2011;26:47–52.

    Article  Google Scholar 

Download references

Acknowledgments

We would like to thank BLDE University, Vijayapur, Karnataka for the research grant towards this study. We thank the staff of the Department of Medicine and Department of Biochemistry, BLDEU’s Shri B M Patil Medical College, Hospital and Research Centre, Vijayapur for Their constant support and motivation for the collection of cases and carrying out investigations. Special thanks to Dr Kusal K Das, Professor, Department of Physiology, BLDEU’s Shri B M Patil Medical College, for valuable suggestions and inspiration. We also thank all the study subjects who took part in this study.

Funding

This study was funded by BLDE University, Vijayapur, 586103, Karnataka, India.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anand K. Pyati.

Ethics declarations

Conflict of interest

Dr Anand K. Pyati, Dr Basavaraj B. Devaranavadagi, Dr Sanjeev L. Sajjannar, Dr Shashikant V. Nikam, Dr Mohd Shannawaz and Dr Satish Patil declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pyati, A.K., Devaranavadagi, B.B., Sajjannar, S.L. et al. Heart-Type Fatty Acid-Binding Protein, in Early Detection of Acute Myocardial Infarction: Comparison with CK-MB, Troponin I and Myoglobin. Ind J Clin Biochem 31, 439–445 (2016). https://doi.org/10.1007/s12291-015-0544-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-015-0544-7

Keywords

Navigation